Edition:
United States

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

5.82USD
12:14pm EDT
Change (% chg)

$-0.14 (-2.35%)
Prev Close
$5.96
Open
$5.93
Day's High
$5.95
Day's Low
$5.63
Volume
31,412
Avg. Vol
70,532
52-wk High
$7.28
52-wk Low
$3.68

Chart for

About

Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule biologics that target medical... (more)

Overall

Beta: 2.39
Market Cap(Mil.): $284.12
Shares Outstanding(Mil.): 47.67
Dividend: --
Yield (%): --

Financials

  PETX.OQ Industry Sector
P/E (TTM): -- 30.48 32.69
EPS (TTM): -0.91 -- --
ROI: -34.11 13.04 12.72
ROE: -40.75 14.99 14.85

BRIEF-Aratana Appoints Craig Barbarosh And Lowell Robinson To Board In Cooperation Agreement With Engaged Capital

* ARATANA THERAPEUTICS APPOINTS CRAIG BARBAROSH AND LOWELL ROBINSON TO ITS BOARD OF DIRECTORS IN COOPERATION AGREEMENT WITH ENGAGED CAPITAL

May 21 2018

BRIEF-Aratana Therapeutics Q1 Loss Per Share $0.19

* ARATANA THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 03 2018

BRIEF-Engaged Capital Reports 5.2 Pct Stake In Aratana Therapeutics Inc, As Of April 4, 2018 SEC Filing

* ENGAGED CAPITAL LLC SAYS PURCHASED ARATANA THERAPEUTICS' SHARES BASED ON BELIEF THAT THE SHARES, WHEN PURCHASED, WERE UNDERVALUED

Apr 05 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF81.80 -0.08
Merck & Co., Inc. (MRK.N) $70.79 -0.31
Bayer AG (BAYGn.DE) €76.15 -0.37
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.86 -0.64
Eli Lilly And Co (LLY.N) $106.00 -0.33
Zoetis Inc (ZTS.N) $89.41 -0.42
Virbac SA (VIRB.PA) €144.20 +2.20
Vetoquinol SA (VETO.PA) €51.00 -1.00
Dechra Pharmaceuticals plc (DPH.L) 2,300.00 -22.00

Earnings vs. Estimates